• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thrombosis (2100); Ulcer (2274)
Event Date 04/27/2020
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.(b)(6).
 
Event Description
It was reported that thrombosis occurred.The 100% stenosed target lesion was located in non-severely calcified and moderately tortuous left superficial femoral artery (sfa).On (b)(6) 2019, a 7x80x130, 7x40x130 and two 7x120x130 eluvia self expanding stents were implanted at the target lesion.On 9 month follow-up visit, the patient was doing good.On (b)(6) 2020, one week before the 12-month follow-up schedule visit, the patient presented with severe lameness symptom and condition was not good.Echocardiogram (echo) revealed occlusion thrombosis inside the stents.It was also noted a foot ulcer.The ulcer was not on the site of eluvia placement.The patient was taking dual antiplatelet therapy (dapt) at 12 months when occlusion was found.On (b)(6) 2020, the thrombosis and foot ulcer treated by performing stent graft with non-bsc device, plain old balloon angioplasty (poba) performed in common femoral artery (cfa) and the eluvia lesion location.The ulcer was healed and severe lameness symptom was disappeared after the treatment.No further complications were reported and the patient status post procedure was fine after the retreatment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC SCIMED, INC
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key10252354
MDR Text Key198160428
Report Number2134265-2020-09057
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 07/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/09/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/13/2020
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0023093799
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/18/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/14/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BEASTOR BSJINFLATION DEVICE; DESTINATION 6FR, 45CMINTRODUCER SHEATH; GLADIUS GUIDEWIRE 0.014INCH, 200CM; GORE VIABAHN - (STENT GRAFT); PROMINENT 2.6FR, 150CM MICROCATHETER; SHIDEN HP 6.0-150MMBALLOON CATHETER
Patient Outcome(s) Required Intervention;
Patient Age78 YR
-
-